To the best of our knowledge, this is the first demonstration that CNS-infecting pathogens exploit EGFR-ACTN4 for their successful invasion of the BBB, suggesting that the EGFR-ACTN4 cascade may offer targets for the better prevention and treatment of bacterial meningitis. The gene discussed is EGFR; the disease is bacterial meningitis.